On Wednesday 19th April 2017, Sartorius Stedim BioOutsource were named as Scottish Life Sciences Company of the Year at the Made in Scotland awards. The annual Made in Scotland awards rewards Scottish companies that have innovative products and services and have subsequently found success domestically and internationally. We were delighted to be announced as the winner More
Register for our webinar on the 29th of June 2017 to find out from our experts how a Quality by Design approach can de-risk biosimilar development.
It’s not as easy as ADCC…Avoid costly pitfalls during the development of your biosimilar by accurately determining ADCC activity. Watch our video to learn how ADCC assays can help unpick the issues of similarity between innovator and biosimilar drugs.
Read our manufacturing of cell banks brochure.
View our latest poster on structure-function relationships of biosimilars.
• Biopharma provider purchases property in Science Park III of Ulm • Laboratory and office facility to be constructed on the site by 2019 Göttingen/Laupheim, December 14, 2016 – Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track. At the end of November, the company in its eleventh year since More
New services to enable U.S. biopharmaceutical companies to accelerate development of biosimilar. Goettingen, Germany | Boston, MA, USA – November 10, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, opened a new bioanalytical and biosafety testing laboratory yesterday in the major biotech hub of Boston, Massachusetts. This dedicated bioanalytical laboratory More
Read our biosafety testing services brochure.
Collaborative poster with DiscoverX on the development and evaluation of novel bioassay for Denosumab activity.
Improve speed to clinic and mitigate risk with appropriate analytical analysis View webinar here.